Cosegregation of a novel mutation in the sixth transmembrane segment of the luteinizing/choriogonadotropin hormone receptor with two Brazilian siblings with severe testotoxicosis

References

• Boot AM, Lumbroso S, Verhoef-Post M, et al. Mutation analysis of the LH receptor gene in Leydig cell adenoma and hyperplasia and functional and biochemical studies of activating mutations of the LH receptor gene. J Clin Endocrinol Metab. 2011;96:E1197–1205.
   Google Scholar
• Eyssette-Guerreau S, Pinto G, Sultan A, et al. Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty. J Pediatr Endocrinol Metab. 2008;21:995–1002.
   PubMed Web of Science ®Google Scholar
• Latronico AC, Costa EM, Domenice S, et al. Clinical and molecular analysis of human reproductive disorders in Brazilian patients. Braz J Med Biol Res. 2004;37:137–144.
   PubMed Web of Science ®Google Scholar
• Themmen APN, Huhtaniemi IT. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr Rev. 2000;21:551–583.
   PubMed Web of Science ®Google Scholar
• Eunice M, Philibert P, Kulshreshtha B, et al. Mother-to-son transmission of a luteinizing hormone receptor activating mutation in a prepubertal child with testotoxicosis. J Pediatr Endocrinol Metab. 2009;22:275–279.
   PubMed Web of Science ®Google Scholar
• Jeha GS, Lowenthal ED, Chan WY, et al. Variable presentation of precocious puberty associated with the D564G mutation of the LHCGR gene in children with testotoxicosis. J Pediatr. 2006;149:271–274.
   PubMed Web of Science ®Google Scholar
• Nagasaki K, Katsumata N, Ogawa Y, et al. Novel C617Y mutation in the 7th transmembrane segment of luteinizing hormone/choriogonadotropin receptor in a Japanese boy with peripheral precocious puberty. Endocr J. 2010;57:1055–1060.
   PubMed Web of Science ®Google Scholar
• Reiter E O, Norjavaara E. Testotoxicosis: current viewpoint. Pediatr Endocrinol Rev. 2005;3:77–86.
   PubMedGoogle Scholar
• Latronico AC, Anasti J, Arnhold IJ, et al. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab. 1995;80:2490–2494.
   PubMed Web of Science ®Google Scholar
• Latronico AC, Abell AN, Arnhold IJ, et al. A unique constitutively activating mutation in third transmembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty. J Clin Endocrinol Metab. 1998;83:2435–2440.
   PubMed Web of Science ®Google Scholar
• Latronico AC, Lins TS, Brito VN, et al. The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary-gonadal axis in both sexes. Clin Endocrinol (Oxf). 2000;53:609–613.
   PubMed Web of Science ®Google Scholar
• Latronico AC, Shinozaki H, Guerra-Junior G, et al. Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix. J Clin Endocrinol Metab. 2000;85:4799–4805.
   PubMed Web of Science ®Google Scholar
• Teles M, Brito VN, Arnhold IJ, et al. Preclinical diagnosis of testotoxicosis in a boy with an activating mutation of the luteinizing hormone receptor. J Pediatr Endocrinol Metab. 2006;19:541–544.
   PubMed Web of Science ®Google Scholar
• Venselaar H, Te Beek TA, Kuipers RK, et al. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics. 2010;11:548.
   Google Scholar
• Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969;44:291–303.
   PubMed Web of Science ®Google Scholar
• Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970;45:13–23.
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics. Centers for Disease Control and Prevention Growth Charts, 2000. Available at http://www.cdc.gov/growthcharts/clinical_charts.htm. [accessed 10 Feb 2016].
   Google Scholar
• Kizys MM, Cardoso MG, Lindsey SC, et al. Optimizing nucleic acid extraction from thyroid fine-needle aspiration cells in stained slides, formalin-fixed/paraffin-embedded tissues, and long-term stored blood samples. Arq Bras Endocrinol Metabol. 2012;56:618–626.
   PubMed Web of Science ®Google Scholar
• Gromoll J, Partsch CJ, Simoni M, et al. A mutation in the first transmembrane domain of the lutropin receptor causes male precocious puberty. J Clin Endocrinol Metab 1998;83:476–480.
   PubMed Web of Science ®Google Scholar
• Evans BA, Bowen DJ, Smith PJ, et al. A new point mutation in the luteinising hormone receptor gene in familial and sporadic male limited precocious puberty: genotype does not always correlate with phenotype. J Med Genet. 1996; 33:143–147.
   PubMed Web of Science ®Google Scholar
• Ignacak M, Hilczer M, Zarzycki J, et al. Substitution of M398T in the second transmembrane helix of the LH receptor in a patient with familial male-limited precocious puberty. Endocr J. 2000;47:595–599.
   PubMed Web of Science ®Google Scholar
• Mao JF, Wu XY, Nie M, et al. [A report of familial male-limited precocious puberty caused by a germ-line heterozygous mutation (M398T) in luteinizing hormone receptor gene]. Zhonghua Nei Ke Za Zhi. 2010;49:1024–1027.
   Google Scholar
• Laue L, Chan WY, Hsueh AJ, et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA. 1995;92:1906–1910.
   PubMed Web of Science ®Google Scholar
• Kremer H, Mariman E, Otten BJ, et al. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum Mol Genet. 1993;2:1779–1783.
   PubMed Web of Science ®Google Scholar
• Kosugi S, Van Dop C, Geffner ME, et al. Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum Mol Genet. 1995;4:183–188.
   PubMed Web of Science ®Google Scholar
• Yano K, Saji M, Hidaka A, et al. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. J Clin Endocrinol Metab. 1995;80:1162–1168.
   PubMed Web of Science ®Google Scholar
• Laue L, Wu SM, Kudo M, et al. Heterogeneity of activating mutations of the human luteinizing hormone receptor in male-limited precocious puberty. Biochem Mol Med. 1996;58:192–198.
   PubMedGoogle Scholar
• Kremer H, Martens JW, van Reen M, et al. A limited repertoire of mutations of the luteinizing hormone (LH) receptor gene in familial and sporadic patients with male LH-independent precocious puberty. J Clin Endocrinol Metab. 1999;84:1136–1140.
   PubMed Web of Science ®Google Scholar
• Cocco S, Meloni A, Marini MG, et al. A missense (T577I) mutation in the luteinizing hormone receptor gene associated with familial male-limited precocious puberty. Hum Mutat. 1996; 7:164–166.
   PubMed Web of Science ®Google Scholar
• Müller J, Gondos B, Kosugi S, et al. Severe testotoxicosis phenotype associated with Asp578–>Tyr mutation of the lutrophin/choriogonadotrophin receptor gene. J Med Genet. 1998;35:340–341.
   PubMed Web of Science ®Google Scholar
• Liu G, Duranteau L, Carel JC, et al. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med. 1999;341:1731–1736.
   PubMed Web of Science ®Google Scholar
• Richter-Unruh A, Wessels HT, Menken U, et al. Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor. J Clin Endocrinol Metab. 2002;87:1052–1056.
   Google Scholar
• Richter-Unruh A, Jorch N, Wessels HT, et al. Venous sampling can be crucial in identifying the testicular origin of idiopathic male luteinising hormone-independent sexual precocity. Eur J Pediatr. 2002;161:668–671.
   PubMed Web of Science ®Google Scholar
• Shenker A, Laue L, Kosugi S, et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature. 1993;365:652–654.
   PubMed Web of Science ®Google Scholar
• Yano K, Hidaka A, Saji M, et al. A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases. J Clin Endocrinol Metab. 1994;79:1818–1823.
   PubMed Web of Science ®Google Scholar
• Kawate N, Kletter GB, Wilson BE, et al. Identification of constitutively activating mutation of the luteinising hormone receptor in a family with male limited gonadotrophin independent precocious puberty (testotoxicosis). J Med Genet. 1995;32:553–554.
   PubMed Web of Science ®Google Scholar
• Wu SM, Leschek EW, Brain C, et al. A novel luteinizing hormone receptor mutation in a patient with familial male-limited precocious puberty: effect of the size of a critical amino acid on receptor activity. Mol Genet Metab. 1999;66:68–73.
   PubMed Web of Science ®Google Scholar
• Almeida MQ, Brito VN, Lins TS, et al. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole. Clin Endocrinol (Oxf). 2008;69:93–98.
   PubMed Web of Science ®Google Scholar
• Lenz AM, Shulman D, Eugster EA, et al. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Pediatrics. 2010;126:e728–733.
   PubMed Web of Science ®Google Scholar
• Mitre N, Lteif A. Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor. J Pediatr Endocrinol Metab. 2009;22:1163–1167.
   PubMed Web of Science ®Google Scholar